Prelude Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-55,275
Closed -$542K 2079
2021
Q4
$542K Hold
55,275
0.01% 739
2021
Q3
$543K Buy
+55,275
New +$543K 0.01% 627